STOCK TITAN
  1. Home
  2. BCYP

Big Cypress Acquisition (BCYP) Stock Price, News & Analysis

BCYP
Published by Stock Titan Data refreshed

What Changed

Price Move History

Daily moves over 5%
2 170 sessions, February 9, 2021 to October 22, 2021
Largest daily move
-19.2% close of October 22, 2021

Company Description

BCYP has declined 15.9% over the past month. The last closing price was $8.44.

This page collects what Stock Titan holds for BCYP, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
-
-
Last updated:
-15.9%
Performance 1 month
-
Market Cap
-
Shares outstanding

Big Cypress Acquisition (BCYP) closed at $8.44 on October 22, 2021. Over the past month, the price has lost 15.9%.

See what a $1,000 investment in BCYP would be worth today

BCYP Metrics & Rankings

Month to date
-16.3%
View ranking

Price returns through October 22, 2021. Month-to-date and YTD include the first trading day. Ranking links may use different dates.

Latest News

View All
+5.24%

Big Cypress Acquisition Corp. Stockholders Approve Business Combination with SAB Biotherapeutics

acquisition
-0.05%

SAB Biotherapeutics to Host Virtual R&D Day on October 13, 2021

conferences
0.00%

SAB Biotherapeutics Announces First Patient Dosed in Phase 3 NIH ACTIV-2 Trial Evaluating SAB-185 for Treatment of COVID-19

clinical trial covid-19
+0.10%

SAB Biotherapeutics Appoints Russell Beyer Chief Financial Officer

management
0.00%

SAB Biotherapeutics Announces SAB-185 Receives Positive DSMB Review and Advances to Phase 3 in NIH-Sponsored ACTIV-2 Trial for Treatment of COVID-19

clinical trial covid-19
+0.29%

Big Cypress Acquisition Corp Announces Special Meeting of Stockholders to Approve Business Combination with SAB Biotherapeutics

acquisition
+0.21%

SAB Biotherapeutics Awarded Additional $60.5M from BARDA and U.S. Department of Defense for Rapid Response Capability and Advancing SAB-185 for Treatment of COVID-19

covid-19
0.00%

SAB Biotherapeutics Announces Completion of Enrollment in Phase 2a Challenge Trial of SAB-176 for the Treatment of Seasonal Influenza

clinical trial
0.00%

SAB Biotherapeutics to Present at Upcoming September Virtual Investor Conferences

conferences
0.00%

SAB Biotherapeutics Announces Nonclinical Data Demonstrating SAB-185 Potently Neutralizes Delta and Lambda SARS-CoV-2 Variants

clinical trial

Big Cypress Acquisition has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 1 with negative movement. Key topics include acquisition, conferences, clinical trial, covid-19, management. View all BCYP news →

SEC Filings

View All

No SEC filings available for BCYP.

Financial Highlights

—
Revenue (latest FY)
—
Net Income (latest FY)
—
Diluted EPS (latest FY)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

Frequently Asked Questions

What is the current quoted price of Big Cypress Acquisition (BCYP)?

The current quoted price of Big Cypress Acquisition (BCYP) is $8.44 as of October 22, 2021.